Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Avesta Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Hayashibara
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Parenteral
Topical
Thickeners and Stabilizers
Fillers, Diluents & Binders
Solubilizers
Taste Masking
Controlled & Modified Release
Chewable & Orodispersible Aids
Surfactant & Foaming Agents
Film Formers & Plasticizers
Lubricants & Glidants
Coating Systems & Additives
Emulsifying Agents
API Stability Enhancers
Rheology Modifiers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
USP
ABOUT THIS PAGE
A Sodium Carboxymethylcellulose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Carboxymethylcellulose, including repackagers and relabelers. The FDA regulates Sodium Carboxymethylcellulose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Carboxymethylcellulose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Carboxymethylcellulose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Carboxymethylcellulose supplier is an individual or a company that provides Sodium Carboxymethylcellulose active pharmaceutical ingredient (API) or Sodium Carboxymethylcellulose finished formulations upon request. The Sodium Carboxymethylcellulose suppliers may include Sodium Carboxymethylcellulose API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Carboxymethylcellulose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Carboxymethylcellulose DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Carboxymethylcellulose active pharmaceutical ingredient (API) in detail. Different forms of Sodium Carboxymethylcellulose DMFs exist exist since differing nations have different regulations, such as Sodium Carboxymethylcellulose USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Carboxymethylcellulose DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Carboxymethylcellulose USDMF includes data on Sodium Carboxymethylcellulose's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Carboxymethylcellulose USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Carboxymethylcellulose suppliers with USDMF on PharmaCompass.
A Sodium Carboxymethylcellulose CEP of the European Pharmacopoeia monograph is often referred to as a Sodium Carboxymethylcellulose Certificate of Suitability (COS). The purpose of a Sodium Carboxymethylcellulose CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium Carboxymethylcellulose EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium Carboxymethylcellulose to their clients by showing that a Sodium Carboxymethylcellulose CEP has been issued for it. The manufacturer submits a Sodium Carboxymethylcellulose CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium Carboxymethylcellulose CEP holder for the record. Additionally, the data presented in the Sodium Carboxymethylcellulose CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium Carboxymethylcellulose DMF.
A Sodium Carboxymethylcellulose CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium Carboxymethylcellulose CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium Carboxymethylcellulose suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Carboxymethylcellulose as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Carboxymethylcellulose API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Carboxymethylcellulose as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Carboxymethylcellulose and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Carboxymethylcellulose NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Carboxymethylcellulose suppliers with NDC on PharmaCompass.
Sodium Carboxymethylcellulose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Carboxymethylcellulose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Carboxymethylcellulose GMP manufacturer or Sodium Carboxymethylcellulose GMP API supplier for your needs.
A Sodium Carboxymethylcellulose CoA (Certificate of Analysis) is a formal document that attests to Sodium Carboxymethylcellulose's compliance with Sodium Carboxymethylcellulose specifications and serves as a tool for batch-level quality control.
Sodium Carboxymethylcellulose CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Carboxymethylcellulose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Carboxymethylcellulose may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Carboxymethylcellulose EP), Sodium Carboxymethylcellulose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Carboxymethylcellulose USP).
LOOKING FOR A SUPPLIER?
